Cargando…

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition

This article updates readers as to what is new in the Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition. Breast cancer screening issues are covered, including matters of breast density and possible supplemental modalities, along with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uematsu, Takayoshi, Nakashima, Kazutaka, Kikuchi, Mari, Kubota, Kazunori, Suzuki, Akihiko, Nakano, Shogo, Hirokaga, Kouichi, Yamaguchi, Ken, Saji, Shigehira, Iwata, Hiroji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2019
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134289/ https://www.ncbi.nlm.nih.gov/pubmed/31734900 http://dx.doi.org/10.1007/s12282-019-01025-7

Ejemplares similares

Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition
por: Uematsu, Takayoshi, et al.
Publicado: (2021)

The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient
por: Iwata, Hiroji, et al.
Publicado: (2019)

Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient
por: Iwata, Hiroji, et al.
Publicado: (2021)

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition
por: Yamauchi, Chikako, et al.
Publicado: (2019)

Correction to: The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition
por: Yamauchi, Chikako, et al.
Publicado: (2021)

The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition
por: Inokuchi, Masafumi, et al.
Publicado: (2019)

Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition
por: Inokuchi, Masafumi, et al.
Publicado: (2021)

Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta‑analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2022 edition
por: Nomura, Tsunehisa, et al.
Publicado: (2023)

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
por: Shimoi, Tatsunori, et al.
Publicado: (2020)

Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
por: Shimoi, Tatsunori, et al.
Publicado: (2021)

A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S−1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG‐M01 study)
por: Ishiguro, Hiroshi, et al.
Publicado: (2017)

Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
por: Saji, Shigehira
Publicado: (2013)

Estradiol Stabilizes p53 Protein in Breast Cancer Cell Line, MCF–7
por: Okumura, Naoki, et al.
Publicado: (2002)

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer
por: Masuda, Norikazu, et al.
Publicado: (2021)

Erratum to: Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
por: Saji, Shigehira
Publicado: (2013)

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication
por: Ueno, Takayuki, et al.
Publicado: (2019)

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition
por: Terada, Mitsuo, et al.
Publicado: (2023)

Impact of body mass index on breast cancer in accordance with the life-stage of women
por: Suzuki, Reiko, et al.
Publicado: (2012)

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer
por: Ogiya, Rin, et al.
Publicado: (2017)

Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group
por: Sawaki, Masataka, et al.
Publicado: (2018)

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples
por: Iwamoto, Takayuki, et al.
Publicado: (2019)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

Imaging features of breast cancer with marked hemosiderin deposition: A case report
por: Harada, Taiyo L., et al.
Publicado: (2019)

Estradiol promotes rapid degradation of HER3 in ER-positive breast cancer cell line MCF-7
por: Suga, Junko, et al.
Publicado: (2018)

Social isolation and cancer management after the 2011 triple disaster in Fukushima, Japan: A case report of breast cancer with patient and provider delay
por: Ozaki, Akihiko, et al.
Publicado: (2016)

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy
por: Ueno, Takayuki, et al.
Publicado: (2016)

Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer Society
por: Kawate, Takahiko, et al.
Publicado: (2021)

Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
por: Toi, Masakazu, et al.
Publicado: (2010)

Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management
por: Yoshimura, Akiyo, et al.
Publicado: (2022)

Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network
por: Kiso, Marina, et al.
Publicado: (2018)

Non-mass lesions on breast ultrasound: why does not the ACR BI-RADS breast ultrasound lexicon add the terminology?
por: Uematsu, Takayoshi
Publicado: (2023)

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
por: Honma, Naoko, et al.
Publicado: (2015)

A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer
por: Takada, Masahiro, et al.
Publicado: (2023)

Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR
por: Ueno, Takayuki, et al.
Publicado: (2019)

Role of MDM2 Overexpression in Doxorubicin Resistance of Breast Carcinoma
por: Suzuki, Akio, et al.
Publicado: (1998)

Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
por: Uehiro, Natsue, et al.
Publicado: (2016)

Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS)
por: Yamamoto, Yutaka, et al.
Publicado: (2022)

Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan
por: Ohnuki, Koji, et al.
Publicado: (2021)

Peritoneal dissemination of breast cancer diagnosed by laparoscopy
por: Nakagawa, Tsuyoshi, et al.
Publicado: (2020)

Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer
por: SAWAKI, MASATAKA, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_npl9vf08ui0vbld2dbv52d3fnp